RPH PHARMA LTD

11330646
Active Cheadle Royal Business Park

Wholesale of pharmaceutical goods

5 employees website.com
Wholesale of pharmaceutical goods
R

RPH PHARMA LTD

11330646

Wholesale of pharmaceutical goods

Founded 26 Apr 2018 Active Cheadle Royal Business Park, England 5 employees website.com
Wholesale of pharmaceutical goods
Accounts Submitted 26 Sept 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 8 May 2026 Next due 9 May 2027 10 months remaining
Net assets £1M £720K 2024 year on year
Total assets £11M £10M 2024 year on year
Total Liabilities £10M £9M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

C/O Pure Offices Suite 71 Brooks Drive Cheadle Royal Business Park Cheadle SK8 3TD England

Full company profile for RPH PHARMA LTD (11330646), an active company based in Cheadle Royal Business Park, England. Incorporated 26 Apr 2018. Wholesale of pharmaceutical goods. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Balance Sheet & P&L (2018–2024)

Cash in Bank

N/A

Decreased by £480.80k (-100%)

Net Assets

£1.34M

Increased by £720.05k (+117%)

Total Liabilities

£9.80M

Increased by £9.02M (+1149%)

Turnover

£13.53M

Increased by £10.66M (+371%)

Employees

5

Debt Ratio

88%

Increased by 32 (+57%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Chouhan, Kieran CharlesDirectorBritishCanada411 Sept 2023Active

Shareholders

Shareholders (1)

Rph Pharmaceuticals Ab
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Eqt Ab (publ)

Sweden

Active
Notified 15 Feb 2021
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent

Group Structure

Group Structure

RPH PHARMA LTD Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
8 May 2026Confirmation StatementConfirmation statement made on 25 Apr 2026 with no updates
26 Sept 2025AccountsAnnual accounts made up to 31 Dec 2024
20 May 2025OfficersTermination of Gregor Johann Kawaletz as director on 16 May 2025
8 May 2025Confirmation StatementConfirmation statement made on 25 Apr 2025 with no updates
25 Sept 2024AccountsAnnual accounts made up to 31 Dec 2023
8 May 2026 Confirmation Statement

Confirmation statement made on 25 Apr 2026 with no updates

26 Sept 2025 Accounts

Annual accounts made up to 31 Dec 2024

20 May 2025 Officers

Termination of Gregor Johann Kawaletz as director on 16 May 2025

8 May 2025 Confirmation Statement

Confirmation statement made on 25 Apr 2025 with no updates

25 Sept 2024 Accounts

Annual accounts made up to 31 Dec 2023

Recent Activity

Latest Activity

Confirmation statement made on 25 Apr 2026 with no updates

1 months ago on 8 May 2026

Annual accounts made up to 31 Dec 2024

8 months ago on 26 Sept 2025

Termination of Gregor Johann Kawaletz as director on 16 May 2025

1 years ago on 20 May 2025

Confirmation statement made on 25 Apr 2025 with no updates

1 years ago on 8 May 2025

Annual accounts made up to 31 Dec 2023

1 years ago on 25 Sept 2024